Palatin Technologies

Palatin Technologies

Palatin Technologies

Palatin Technologies, a biopharmaceutical company, develops targeted receptorspecific peptide therapeutics for the treatment of diseases.
Founded
1986
Raised
$16.5M
Follow us
Alexa global traffic share
Twitter followers
Latest funding
$16,500,000
Post-IPO equity - 2016
Team Size
50+
Employees
$16,500,000 Post-IPO equity
biospace

Palatin Tech Closes On 16 5 Million Financing